Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction

Rubin Bressler, Richard Gay, Jack G. Copeland, Joseph J. Bahl, John Bedotto, Steve Goldman

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


The proportion of cardiac energy derived from fatty acid oxidation decreases and that derived from glucose increases during ischemia. This biochemical profile of cardiac energy production is achieved in rats and mice without ischemia by pharmacological agents such as tetradecylglycidic acid. Chronically this leads to increased cardiac stiffness, and hypertrophy in the rodent models. Elements of human cardiac dysfunction are hypothesized to develop from and/or cause similar changes in substrate utilization for energy production. For some individuals treatment that would prevent or reverse these changes may be appropriate.

Original languageEnglish (US)
Pages (from-to)1897-1906
Number of pages10
JournalLife Sciences
Issue number25
StatePublished - 1989

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction'. Together they form a unique fingerprint.

Cite this